148 related articles for article (PubMed ID: 37435540)
1. Clinical, dermoscopic, and ultrasonic monitoring of the response to biologic treatment in patients with moderate-to-severe plaque psoriasis.
Wang J; Zhu Q; Li F; Xiao M; Liu J
Front Med (Lausanne); 2023; 10():1162873. PubMed ID: 37435540
[TBL] [Abstract][Full Text] [Related]
2. Improve the dupilumab therapy evaluation with dermoscopy and high-frequency ultrasound in moderate-to-severe atopic dermatitis.
Liu Z; Niu Z; Zhang D; Liu J; Zhu Q
Skin Res Technol; 2023 Jan; 29(1):e13260. PubMed ID: 36704877
[TBL] [Abstract][Full Text] [Related]
3. Ultra-high-frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment.
Dini V; Janowska A; Faita F; Panduri S; Benincasa BB; Izzetti R; Romanelli M; Oranges T
Skin Res Technol; 2021 Mar; 27(2):277-282. PubMed ID: 33529441
[TBL] [Abstract][Full Text] [Related]
4. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
5. Plaque-Type Psoriasis Treated with Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam: A Prospective Study on Clinical and Dermoscopic Predictor Factors in Response Achievement and Retention.
Errichetti E; Croatto M; Arnoldo L; Stinco G
Dermatol Ther (Heidelb); 2020 Aug; 10(4):757-767. PubMed ID: 32533555
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study.
Crowley JJ; Langley RG; Gordon KB; Pinter A; Ferris LK; Rubant S; Photowala H; Xue Z; Wu T; Zhan T; Beeck S; Shah M; Warren RB
Dermatol Ther (Heidelb); 2022 Feb; 12(2):561-575. PubMed ID: 35050485
[TBL] [Abstract][Full Text] [Related]
7. Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents.
Lallas A; Argenziano G; Zalaudek I; Apalla Z; Ardigo M; Chellini P; Cordeiro N; Guimaraes M; Kyrgidis A; Lazaridou E; Longo C; Moscarella E; Papadimitriou I; Pellacani G; Sotiriou E; Vakirlis E; Ioannides D
Dermatol Pract Concept; 2016 Oct; 6(4):7-12. PubMed ID: 27867739
[TBL] [Abstract][Full Text] [Related]
8. Can Dermoscopy and Ultrasonography be Considered a Prognostic Tool in Management of Psoriasis?
Muralidharan E; Malhotra SK; Singh A
Indian J Dermatol; 2021; 66(6):704. PubMed ID: 35283496
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopic Features of Psoriatic Nails and Their Correlation to Disease Severity.
Mashal ZR; Elgamal EEA; Zaky MS; Elsaie ML
Dermatol Res Pract; 2023; 2023():4653177. PubMed ID: 37223320
[TBL] [Abstract][Full Text] [Related]
10. Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment.
Dini V; Iannone M; Michelucci A; Manzo Margiotta F; Granieri G; Salvia G; Oranges T; Janowska A; Morganti R; Romanelli M
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685259
[TBL] [Abstract][Full Text] [Related]
11. Assessment of vascular patterns during the treatment of psoriatic patients using narrow-band ultraviolet B phototherapy by the dermoscope.
El Sayed M; Lotfi R; Hossam D; Onsy P; Elhawatky A
Photodermatol Photoimmunol Photomed; 2023 Mar; 39(2):100-106. PubMed ID: 36653943
[TBL] [Abstract][Full Text] [Related]
12. Study of Nail Psoriasis and Dermoscopic Correlation with Dermoscopic and Modified Dermoscopic Nail Psoriasis Severity Indexes (dNAPSI and dmNAPSI).
Arora S; Paul D; Kumar R; Bhatnagar A; Arora G; Mech S; Suhag DK
Dermatol Pract Concept; 2022 Feb; 12(1):e2022010. PubMed ID: 35223155
[TBL] [Abstract][Full Text] [Related]
13. [Roles of dermoscopy in differential diagnosis of psoriasis and eczema].
Xu C; Liu J; Chen D; Liu Y; Sun Q
Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(36):2833-7. PubMed ID: 25534101
[TBL] [Abstract][Full Text] [Related]
14. Dermoscopic features of nail psoriasis treated with biologics.
Hashimoto Y; Uyama M; Takada Y; Yoshida K; Ishiko A
J Dermatol; 2017 May; 44(5):538-541. PubMed ID: 28150346
[TBL] [Abstract][Full Text] [Related]
15. Combined clinical, capillaroscopic and ultrasound evaluation during treatment of plaque psoriasis with oral cyclosporine.
Musumeci ML; Lacarrubba F; Fusto CM; Micali G
Int J Immunopathol Pharmacol; 2013; 26(4):1027-33. PubMed ID: 24355242
[TBL] [Abstract][Full Text] [Related]
16. Clinical and dermoscopic response predictors in psoriatic patients undergoing narrowband ultraviolet B phototherapy: results from a prospective study.
Errichetti E; Stinco G
Int J Dermatol; 2018 Jun; 57(6):681-686. PubMed ID: 29604040
[TBL] [Abstract][Full Text] [Related]
17. Clinical, ultrasound, and videodermatoscopy monitoring of psoriatic patients following biological treatment.
Micali G; Lacarrubba F; Santagati C; Egan CG; Nasca MR; Musumeci ML
Skin Res Technol; 2016 Aug; 22(3):341-8. PubMed ID: 26450445
[TBL] [Abstract][Full Text] [Related]
18. Dermoscopy of plaque psoriasis differs with plaque location, its duration, and patient's sex.
Golińska J; Sar-Pomian M; Rudnicka L
Skin Res Technol; 2021 Mar; 27(2):217-226. PubMed ID: 32691452
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Mild-to-Moderate Plaque Psoriasis with a New 650-Microsecond 1064-nm Nd:YAG Laser: Clinical and Dermoscopic Assessment.
Kołt-Kamińska M; Żychowska M; Reich A
Dermatol Ther (Heidelb); 2021 Apr; 11(2):449-464. PubMed ID: 33464472
[TBL] [Abstract][Full Text] [Related]
20. Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial.
Augustin M; Reich K; Yamauchi P; Pinter A; Bagel J; Dahale S; You R; Bruin G; Djimopoulos J; Paguet B; Charef P; Patekar M; Keefe D
Br J Dermatol; 2022 Jun; 186(6):942-954. PubMed ID: 34981829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
